ClinicalTrials.gg
Active, not recruitingNCT05322837Updated Oct 7, 2026

Tracking of Upper Limb Sensory and Motor Recovery in Asian Stroke Survivors

An observational study in Stroke, sponsored by Tan Tock Seng Hospital. Active, not recruiting at 1 site in Singapore. Open to participants aged 21 Years to 90 Years. Per ClinicalTrials.gov, last updated 2026-10-07.

Sponsored by Tan Tock Seng Hospital · Observational

How we know

Updated Oct 7, 2026Now Active, not recruitingPrimary completion moved+2 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
107
Ages
21 Years to 90 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 29 studies in Stroke by Tan Tock Seng Hospital — 3 open to participants now, 6 under way, none of them phase 3. Stroke · Tan Tock Seng Hospital.

Started
2023
the only one that year
Observational
9 of 29
1 open now
Registered
17th of 29
by date

Among the 29 studies in Stroke by Tan Tock Seng Hospital, this one is the only one that started in 2023, is one of 9 observational ones, and was the 17th registered.

Stroke

8,283 studies on the registry are indexed under Stroke; 2,065 are open to participants now.

Browse Stroke studies →

Open to participants now

3 of the 29 studies in Stroke by Tan Tock Seng Hospital are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 3 open studies →

Where they have run

Who these studies take

Of the 1,418 Stroke studies recruiting now, 698 (49%) set no upper age limit and 281 (20%) stop at 75 or younger; 77 take children under 18; 197 take healthy volunteers.

This study: 21 Years to 90 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 29 studies in Stroke by Tan Tock Seng Hospital, or all of them as a file.
02

Study summary

As Singapore's population is aging rapidly, the incidence rate of stroke has been increasing in the past years. Rehabilitation is essential for the resumption of daily activities, and with the appropriate care, it is possible for stroke-survivors to regain most of their functions.

Hence, this study aims to better understand upper limb recovery covering different stages post-stroke in a representative cohort of Asian adults

Read the detailed description

Stroke is a leading contributor to disability in Singapore, partially driven by a reduced ability to use the upper limb in their daily lives. Reduced upper limb use commonly results from a variety of impairments such as motor, sensory and cognitive impairments.

The aim of this longitudinal and observational study is to gather a rich multi-modal database on the time-course of upper limb recovery in a representative cohort after stroke and characterise the relationship between upper limb recovery, common post-stroke impairments and quality of life.

03

Conditions studied

  • Stroke

Browse trials for

04

Who can participate

Ages eligible
21 Years to 90 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients admitted to inpatient rehabilitation unit

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Stroke confirmed by neurologists, neurosurgeons and brain imaging (CT, CT angiogram, MRI, MR angiogram)
  2. First ever confirmed stroke
  3. Asian ethnicity
  4. Age 21-90 years
  5. (MOCA) scores 21/30 and above
  6. Admission to rehabilitation ward is within 8 weeks of stroke onset

Exclusion criteria

Exclusion Criteria:

  1. Recurrent stroke or (TIA)
  2. Upper limb impairment not related to stroke: e.g., subarachnoid haemorrhage, traumatic brain injury or brain tumours
  3. Bilateral upper limb impairment.
  4. Uncontrolled medical conditions such as hypertension, hypotension, diabetes mellitus, unstable angina, cardiac failure or sepsis will be excluded.
  5. Active fractures or arthritis of upper limb joints/bones
  6. Visual Analogue Scale (VAS) pain > 5/10
  7. MOCA \< 21/30
  8. Severe behavioural disturbance or agitation or epilepsy or untreated depression
  9. \< 6 months
  10. End organ failures on replacements (renal dialysis or renal replacement therapies)
  11. Minimally responsive or unresponsive awareness (vegetative) states
  12. Pregnancy or lactation states
  13. Admission to rehab ward later than 8 weeks post-stroke
  14. (For TMS assessments only) History of epilepsy or seizures, or cranial surgeries, or have metal implants in body or head, or have implanted electronics, or have metallic valve, or skull fracture or brain injury, or head or brain surgeries.
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

MMSE and MoCA

Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.

TIA (transient ischaemic attack)

A “mini-stroke”: temporary stroke-like symptoms caused by reduced blood flow to part of the brain, spinal cord or eye, without signs of a new stroke on a scan.

Stroke symptoms need emergency care at once, even if they go away.

Life expectancy

The study doctor’s estimate of how long someone is likely to live. Criteria use it so that people can stay in the study long enough for it to answer its question.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
107 participants (actual)
Patient registry
No

Groups and cohorts

  • Intervention

    Other: Clinical and technological-aided assessments and questionnaires

Interventions

  • OtherClinical and technological-aided assessments and questionnaires

    Assessments and questionnaires related to upper limb function and quality of life will be used

06

What researchers measure

Primary outcomes

  1. Fugl-Meyer Assessment (FMA)

    The FMA-UE is a stroke-specific, performance-based impairment index. It is designed to assess motor functioning, balance, in patients with post-stroke hemiplegia.

    Time frame: Inpatient: week 1 of admission

07

Study locations

1 site
08

References and documents

Publications

  • Cheng HJ, Chin LF, Kanzler CM, Lehner R, Kuah CWK, Kager S, Josse E, Samkharadze T, Sidarta A, Gonzalez PC, Lie E, Zbytniewska-Megret M, Wee SK, Liang P, Gassert R, Chua K, Lambercy O, Wenderoth N. Upper limb sensorimotor recovery in Asian stroke survivors: a study protocol for the development and implementation of a Technology-Assisted dIgitaL biOmaRker (TAILOR) platform. Front Neurol. 2023 Nov 30;14:1246888. doi: 10.3389/fneur.2023.1246888. eCollection 2023. PubMed 38107648 ↗

Individual participant data

Plan to share: No

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Apr 2023 (actual). Primary completion is estimated for Dec 2027, 56 months after the start.

Of 838 non-industry observational studies under Stroke, half reached primary completion within 41 months of starting (the median), counting those still running; a quarter within 18 and three quarters within 92. This study's planned 56 months is above that.

Counting every sponsor, half of 900 studies reached it within 40 months; a quarter within 18 and three quarters within 85.

Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 7, 2026: primary completion Jan 2026 → Dec 2027 and completion Jan 2026 → Dec 2027.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Apr 1, 2022
First posted
Apr 12, 2022
StartActual
Apr 26, 2023
Primary completionEst.
Dec 31, 2027was Jan 2026
CompletionEst.
Dec 31, 2027was Jan 2026
Last update
Oct 7, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Recruiting→Active, not recruiting
changed Oct 7, 2026
Primary completion
Jan 2026→Dec 31, 2027
Oct 7, 2026
Study completion
Jan 2026→Dec 31, 2027
Oct 7, 2026
Enrollment
400 (estimated)→107 (actual)
Oct 7, 2026
Publications
1 publication citing this study linked from PubMed, e.g. PubMed 38107648 ↗
Oct 7, 2026
Show all 1 update
  1. Oct 7, 2026
    Recruiting→Active, not recruiting
    Publications 1 publication citing this study linked from PubMed, e.g. PubMed 38107648 ↗
    Primary completion Jan 2026→Dec 31, 2027
    Study completion Jan 2026→Dec 31, 2027
    Enrollment 400 (estimated)→107 (actual)
    + 5 other changes: index terms, verification date, oversight details, contact details and site details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT05322837
Collaborators
Rehabilitation Research Institute of Singapore (RRIS), Singapore-ETH Centre (SEC)
Responsible party
Sponsor
First posted
Apr 12, 2022
Start date
Apr 26, 2023
Primary completion
Dec 31, 2027 (estimated)
Completion
Dec 31, 2027 (estimated)
Last update
Oct 7, 2026

Study contacts

Dr Karen Chua, MBBS
principal investigator · Tan Tock Seng Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion